COVID-19 mortality and adverse outcomes in US patients with or without cancer
Prof. Sharon Gordiano
As the COVID-19 pandemic continues, understanding the clinical outcomes of patients with cancer and COVID-19 has become critically important. A cohort study of 507,307 patients with COVID-19 found that those with cancer who received anticancer treatment within 3 months before COVID-19 diagnosis had an increased risk of death, intensive care unit admission, and hospitalization. Patients without recent cancer treatment had similar or better outcomes than patients without cancer.
